Cutter & Company Brokerage Lowered Its Novo Nordisk A S Adr (NVO) Holding; 4 Analysts Covering GDI Integrated Facility Services Inc. (TSE:GDI)

May 22, 2018 - By Peter Mason

Novo Nordisk A/S (NYSE:NVO) Logo

Cutter & Company Brokerage Inc decreased Novo Nordisk A S Adr (NVO) stake by 4.45% reported in 2017Q4 SEC filing. Cutter & Company Brokerage Inc sold 7,870 shares as Novo Nordisk A S Adr (NVO)’s stock declined 9.08%. The Cutter & Company Brokerage Inc holds 169,171 shares with $9.08M value, down from 177,041 last quarter. Novo Nordisk A S Adr now has $117.18 billion valuation. The stock decreased 0.12% or $0.06 during the last trading session, reaching $48.63. About 80,025 shares traded. Novo Nordisk A/S (NYSE:NVO) has risen 42.07% since May 22, 2017 and is uptrending. It has outperformed by 30.52% the S&P500.

Among 5 analysts covering GDI Integrated Facility Services Inc (TSE:GDI), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. GDI Integrated Facility Services Inc had 22 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was initiated by GMP Securities with “Buy” on Tuesday, October 6. Scotia Capital maintained GDI Integrated Facility Services Inc. (TSE:GDI) rating on Friday, November 10. Scotia Capital has “Sector Perform” rating and $18 target. TD Securities maintained GDI Integrated Facility Services Inc. (TSE:GDI) on Friday, November 11 with “Hold” rating. The firm has “Buy” rating given on Thursday, March 2 by TD Securities. The rating was maintained by Scotia Capital with “Sector Perform” on Monday, May 15. See GDI Integrated Facility Services Inc. (TSE:GDI) latest ratings:

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 21 analyst reports since August 28, 2015 according to SRatingsIntel. As per Friday, August 28, the company rating was upgraded by Zacks. Morgan Stanley downgraded Novo Nordisk A/S (NYSE:NVO) on Thursday, September 1 to “Equal-Weight” rating. Citigroup downgraded the stock to “Neutral” rating in Monday, October 31 report. The stock has “Buy” rating by Goldman Sachs on Friday, January 19. The stock of Novo Nordisk A/S (NYSE:NVO) has “Hold” rating given on Friday, December 29 by J.P. Morgan. As per Friday, December 29, the company rating was upgraded by JP Morgan. Leerink Swann initiated the stock with “Market Perform” rating in Friday, August 28 report. The stock has “Outperform” rating by BNP Paribas on Tuesday, September 13. Bank of America upgraded Novo Nordisk A/S (NYSE:NVO) on Wednesday, September 6 to “Neutral” rating. DNB Markets downgraded the stock to “Hold” rating in Monday, October 31 report.

More recent Novo Nordisk A/S (NYSE:NVO) news were published by: Globenewswire.com which released: “Report: Developing Opportunities within El Pollo Loco, Chemed, Novo Nordisk A/S, FactSet Research, Fair Isaac, and …” on May 22, 2018. Also Seekingalpha.com published the news titled: “Novo Nordisk: An Objective Analysis” on May 08, 2018. Seekingalpha.com‘s news article titled: “Is Novo Nordisk Undervalued Once Again?” with publication date: April 30, 2018 was also an interesting one.

It closed at $16.5 lastly. It is up 0.00% since May 22, 2017 and is . It has underperformed by 11.55% the S&P500.

Novo Nordisk A/S (NYSE:NVO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Mason

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: